Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on September 1, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

GMP Synthesis of Bulk Drug Testing

Closed
N01DA-24-8915Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

MD

Set-Aside

NONE

Documents

1

GMP Synthesis of Bulk Drug Testing - Sources Sought Notice

PDF, Low prioritysources-sought
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida
Contacts2 people available
OfficeBethesda, MD, 20892, USA

Full Description

Show more
The National Institute on Drug Abuse (NIDA) seeks capability statements from Small Businesses (e.g., 8(a), veteran-owned, service-disabled veteran-owned, HUBZone, small disadvantaged, and woman-owned small businesses). Offerors must provide the Good Manufacturing Practices (GMP) synthesis of bulk drug substances to the medications development program of NIDA for toxicological and clinical trials. Offerors must demonstrate the ability to manufacture bulk drug substances under both GMP following relevant Food and Drug Administration (FDA) guidance and regulations (e.g. Code of Federal Regulations Title 21) and non-GMP. Offerors must indicate experience in producing GMP and non-GMP drug substances in batch sizes of at least one kilogram or larger, appropriately store GMP and non-GMP materials on site, and maintain a facility in good standing with the FDA. Offerors must have onsite access to state-of-the-art equipment for analytical testing (high-performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), liquid chromatography-mass spectrometry (LC-MS), isotope ratio (IR), circular dichroism (CD) and nuclear magnetic resonance (NMR)). Offerors must show experience in preparing reports acceptable in format and substance for adaptation into a Chemistry, Manufacturing and Control (CMC) section for each drug substance for submission to the FDA in support of Investigational New Drug (IND) and New Drug Application (NDA) applications. To handle substances or starting materials under the Controlled Substance Act of 1970, offerors must possess Drug Enforcement Administration (DEA) Research and Manufacturing Registrations for Schedules II to V controlled substances and demonstrate the capability to obtain DEA Research and Manufacturing Registrations for Schedule I controlled substances. Please see the attachment for more details.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

NAICS: 541990
New
Federal
SMART IRB Governance, Administration, and Operations Support (GAOS)
Solicitation # 75N98026Q00287
The National Center for Translational Sciences (NCATS), under the National Institutes of Health, is seeking a partner to provide Governance, Administration, and Operations Support (GAOS) for the SMART IRB portfolio of services. The selected contractor will facilitate user administration, process and workflow improvements, content development and moderation, and requirements gathering. This support extends across three primary systems: the SMARTIRB.org website for education and content distribution, the Joinder system for institutional authorization agreements, and the Online Reliance System (ORS) for documenting study-specific IRB reliance arrangements. This is a full and open competition for commercial services conducted under FAR Part 12 and FAR Subpart 13.5, with a NAICS code of 541990. The anticipated period of performance consists of a 12-month base period starting January 1, 2027, followed by three 12-month option periods and one final 6-month option period ending June 30, 2031. Performance will take place at the contractor's facility. Award decisions will be based on the most advantageous offer, evaluated against management approach and technical capabilities, personnel qualifications, and organizational experience. Key deliverables include monthly status reports, quarterly metrics and analysis, and a final closeout report. All invoices must be processed electronically through the Department of Treasury Invoice Processing Platform.
All Other Professional, Scientific, and Technical Services

POSTED

about 20 hours ago

DEADLINE

in 15 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS